FDA Inspection
Oxford Biomedica (UK) LimitedOxford Biomedica (UK) Limited – FDA Inspection, Feb 20, 2019
Record Details
This FDA Inspection record concerns Oxford Biomedica (UK) Limited, with an inspection on February 20, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 22310181-9aa0-4704-a6f6-4665f2faa926
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1082991
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
Other FDA inspections of Oxford Biomedica (UK) Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 24, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Oxford Biomedica (UK) Limited
- FDA Inspection 1245331 - 2024-06-17
- FDA Inspection 1020060 - 2017-05-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.